Skip to content

Clinical trials

Observational Psychotic Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Observational Country / region: United States Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20041
20053
20065
20074
20082
20092
20104
20112
20122
20132
20143
20163
20173
20182
20194
20201
20214
20222
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting6
Terminated5
Unknown status3
Withdrawn3
Active, not recruiting2
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)8
Stanford University5
University of Minnesota5
NYU Langone Health3
University of Alabama at Birmingham3
University of Maryland, Baltimore3
University of North Carolina, Chapel Hill3
University of Texas Southwestern Medical Center3
Northwell Health2
University of Pittsburgh2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders68
Schizophrenia39
Bipolar Disorder14
Major Depressive Disorder10
Mental Disorders6
Schizophrenia Spectrum and Other Psychotic Disorders4
Anxiety Disorders3
Parkinson Disease3
Weight Gain3
Attention Deficit Disorder with Hyperactivity2

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.